BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 306577)

  • 41. Anaerobic vaginosis: therapeutic and epidemiological aspects.
    Blackwell A
    J Antimicrob Chemother; 1984 Nov; 14(5):445-8. PubMed ID: 6334683
    [No Abstract]   [Full Text] [Related]  

  • 42. A study of the susceptibility of three species of primate to vaginal colonization with Gardnerella vaginalis.
    Johnson AP; Ison CA; Hetherington CM; Osborn MF; Southerton G; London WT; Easmon CS; Taylor-Robinson D
    Br J Exp Pathol; 1984 Jun; 65(3):389-96. PubMed ID: 6611168
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Nonspecific vaginitis and Gardnerella vaginalis: methodological and epidemiological notes on 328 cases].
    Cristiano L; Lorenzi M
    Quad Sclavo Diagn; 1986 Dec; 22(4):398-411. PubMed ID: 3313504
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Bacterial vaginitis within the scope of gynecologic consultation].
    Barten G
    Zentralbl Gynakol; 1987; 109(5):300-4. PubMed ID: 3495945
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of benzydamine in the topical treatment of the so-called non-specific vaginitis.
    Magliano EM; Conti M; Clerici P; Laurita L
    Int J Tissue React; 1987; 9(2):151-6. PubMed ID: 3497131
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathogenicity of Gardnerella vaginalis (Haemophilus vaginalis).
    Gardner HL
    Scand J Infect Dis Suppl; 1983; 40():37-40. PubMed ID: 6607520
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Non-specific (anaerobic) vaginitis: relevance of clinical and laboratory studies in a practice population.
    Kelsey MC; Mann GK; Bangham AM; Milnthorpe J
    J R Coll Gen Pract; 1987 Feb; 37(295):56-8. PubMed ID: 3499507
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of Gardnerella vaginalis vaginitis.
    Tummon IS; Graham Hulley WF
    Can Med Assoc J; 1984 Nov; 131(9):1018. PubMed ID: 6333920
    [No Abstract]   [Full Text] [Related]  

  • 49. Comparison of single-dose vs one-week course of metronidazole for symptomatic bacterial vaginosis.
    Swedberg J; Steiner JF; Deiss F; Steiner S; Driggers DA
    JAMA; 1985 Aug 23-30; 254(8):1046-9. PubMed ID: 3894707
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gardnerella vaginalis and non-specific vaginitis.
    Dyas A; Wise R
    Eur J Clin Microbiol; 1982 Aug; 1(4):201-3. PubMed ID: 6983437
    [No Abstract]   [Full Text] [Related]  

  • 51. Contribution of Gardnerella vaginalis to vaginitis in a general practice.
    O'Dowd TC; West RR; Ribeiro CD; Smail JE; Munro JA
    Br Med J (Clin Res Ed); 1986 Jun; 292(6536):1640-2. PubMed ID: 3013357
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro susceptibility of Gardnerella vaginalis and Bacteroides organisms, associated with nonspecific vaginitis, to sulfonamide preparations.
    Jones BM; Kinghorn GR; Geary I
    Antimicrob Agents Chemother; 1982 Jun; 21(6):870-2. PubMed ID: 6981374
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gardnerella vaginalis, anaerobes, and vaginal discharge.
    Taylor E; Blackwell AL; Barlow D; Phillips I
    Lancet; 1982 Jun; 1(8286):1376-9. PubMed ID: 6123676
    [No Abstract]   [Full Text] [Related]  

  • 54. The prevalence of Gardnerella vaginalis, Trichomonas vaginalis and Candida albicans in the cytology clinic at Ibadan, Nigeria.
    Konje JC; Otolorin EO; Ogunniyi JO; Obisesan KA; Ladipo OA
    Afr J Med Med Sci; 1991 Mar; 20(1):29-34. PubMed ID: 1905467
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Single dose versus seven day metronidazole in Gardnerella vaginalis associated non-specific vaginitis.
    Alawattegama AB; Jones BM; Kinghorn GR; Geary I; Duerden BL
    Lancet; 1984 Jun; 1(8390):1355. PubMed ID: 6145055
    [No Abstract]   [Full Text] [Related]  

  • 56. Bacterial vaginosis. An evaluation of treatment.
    Piot P
    Scand J Urol Nephrol Suppl; 1984; 86():229-35. PubMed ID: 6336137
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vaginal infection with Gardnerella vaginalis.
    Admad FJ; Sayed SM
    Practitioner; 1985 Mar; 229(1401):273-4, 276-7. PubMed ID: 3871942
    [No Abstract]   [Full Text] [Related]  

  • 58. Comparative antimicrobial activity of metronidazole and the hydroxy metabolite against Gardnerella vaginalis.
    Ralph ED
    Scand J Infect Dis Suppl; 1983; 40():115-20. PubMed ID: 6607518
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical prediction of Gardnerella vaginalis in general practice.
    O'Dowd TC; West RR
    J R Coll Gen Pract; 1987 Feb; 37(295):59-61. PubMed ID: 3499508
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Therapy of amine-vaginitis by a single dose of ornidazole (Tiberal); serum and tissue (vagina) concentrations of ornidazole after vaginal or rectal application.
    Petersen E; Sanabria de Isele T; Pelz K
    Chemioterapia; 1987 Jun; 6(2 Suppl):539-40. PubMed ID: 3509939
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.